Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Page 9 of 12

Page 9 of 12 – SEC Filing

(b) Percent of class:

10.4%

(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote               0,
(ii) Shared power to vote or to direct the vote 3,811,821,
(iii) Sole power to dispose or to direct the disposition of               0,
(iv) Shared power to dispose or to direct the disposition of 3,811,821.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response
to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of
employee benefit plan, pension fund or endowment fund is not required.

All securities reported in this Schedule 13G amendment are directly held by advisory clients of
Scopia Capital Management LP. With the exception of Scopia Windmill Fund LP, none of such advisory clients individually holds more than 5% of the Issuers outstanding shares.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b) (1) (ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the
relevant subsidiary.

N/A

Item 8. Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to ss.240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed
this schedule pursuant to §§ 240.13d-1(c) or §§ 240.13d-1(d), attach an exhibit stating the identity of each member of the group.

N/A

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 9 of 12